PG Electroplast Limited (BOM:533581)
India · Delayed Price · Currency is INR 589.05
-146.90 (-19.96%)
At close: Aug 8, 2025
Marinus Pharmaceuticals Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 50,527 | 48,695 | 27,465 | 21,599 | 11,116 | 7,032 | Upgrade |
Other Revenue | 351.06 | 351.06 | - | - | - | - | Upgrade |
| 50,878 | 49,046 | 27,465 | 21,599 | 11,116 | 7,032 | Upgrade | |
Revenue Growth (YoY) | 50.10% | 78.58% | 27.16% | 94.30% | 58.08% | 9.98% | Upgrade |
Cost of Revenue | 40,491 | 38,923 | 22,071 | 17,646 | 8,842 | 5,572 | Upgrade |
Gross Profit | 10,387 | 10,124 | 5,394 | 3,954 | 2,274 | 1,460 | Upgrade |
Selling, General & Admin | 2,894 | 2,728 | 1,693 | 1,245 | 785.49 | 558.5 | Upgrade |
Other Operating Expenses | 2,395 | 2,204 | 1,121 | 866.8 | 540.59 | 384.3 | Upgrade |
Operating Expenses | 6,003 | 5,588 | 3,280 | 2,514 | 1,587 | 1,140 | Upgrade |
Operating Income | 4,384 | 4,535 | 2,114 | 1,440 | 687.18 | 320.15 | Upgrade |
Interest Expense | -1,044 | -888.54 | -337.42 | -290.52 | -151.63 | -113.94 | Upgrade |
Interest & Investment Income | - | - | 113.01 | 31.81 | 20.55 | 11.74 | Upgrade |
Earnings From Equity Investments | -16.18 | -31.25 | -21.12 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | 82.1 | -23.26 | - | - | Upgrade |
Other Non Operating Income (Expenses) | 142.75 | -0 | -168.2 | -179.6 | -78.66 | -62.62 | Upgrade |
EBT Excluding Unusual Items | 3,466 | 3,616 | 1,783 | 978.53 | 477.44 | 155.34 | Upgrade |
Gain (Loss) on Sale of Investments | - | - | 2.58 | 0.17 | 0.42 | 0.15 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | -5.07 | -2.36 | 0.35 | 3.85 | Upgrade |
Asset Writedown | - | - | -2.69 | - | - | -1.28 | Upgrade |
Other Unusual Items | - | - | -33.94 | -0.9 | 12.21 | -6.88 | Upgrade |
Pretax Income | 3,466 | 3,616 | 1,744 | 975.43 | 490.42 | 151.16 | Upgrade |
Income Tax Expense | 755.38 | 737.71 | 394.54 | 200.75 | 116.27 | 35.05 | Upgrade |
Net Income | 2,711 | 2,878 | 1,349 | 774.69 | 374.16 | 116.12 | Upgrade |
Net Income to Common | 2,711 | 2,878 | 1,349 | 774.69 | 374.16 | 116.12 | Upgrade |
Net Income Growth | 46.70% | 113.34% | 74.13% | 107.05% | 222.22% | 344.10% | Upgrade |
Shares Outstanding (Basic) | 273 | 268 | 246 | 216 | 207 | 195 | Upgrade |
Shares Outstanding (Diluted) | 278 | 273 | 249 | 229 | 220 | 195 | Upgrade |
Shares Change (YoY) | 7.84% | 9.34% | 8.75% | 4.40% | 12.51% | 4.07% | Upgrade |
EPS (Basic) | 9.91 | 10.74 | 5.47 | 3.58 | 1.81 | 0.59 | Upgrade |
EPS (Diluted) | 9.74 | 10.55 | 5.41 | 3.38 | 1.70 | 0.59 | Upgrade |
EPS Growth | 36.04% | 95.12% | 60.11% | 98.30% | 186.42% | 327.76% | Upgrade |
Free Cash Flow | - | -5,648 | -404.67 | -1,088 | -2,359 | 132.03 | Upgrade |
Free Cash Flow Per Share | - | -20.70 | -1.62 | -4.74 | -10.74 | 0.68 | Upgrade |
Dividend Per Share | - | 0.250 | 0.200 | - | - | - | Upgrade |
Dividend Growth | - | 25.00% | - | - | - | - | Upgrade |
Gross Margin | 20.42% | 20.64% | 19.64% | 18.30% | 20.46% | 20.76% | Upgrade |
Operating Margin | 8.62% | 9.25% | 7.70% | 6.67% | 6.18% | 4.55% | Upgrade |
Profit Margin | 5.33% | 5.87% | 4.91% | 3.59% | 3.37% | 1.65% | Upgrade |
Free Cash Flow Margin | - | -11.52% | -1.47% | -5.04% | -21.22% | 1.88% | Upgrade |
EBITDA | 5,105 | 5,192 | 2,511 | 1,751 | 887.82 | 487.44 | Upgrade |
EBITDA Margin | 10.03% | 10.59% | 9.14% | 8.11% | 7.99% | 6.93% | Upgrade |
D&A For EBITDA | 720.94 | 656.14 | 396.95 | 310.49 | 200.64 | 167.28 | Upgrade |
EBIT | 4,384 | 4,535 | 2,114 | 1,440 | 687.18 | 320.15 | Upgrade |
EBIT Margin | 8.62% | 9.25% | 7.70% | 6.67% | 6.18% | 4.55% | Upgrade |
Effective Tax Rate | 21.79% | 20.40% | 22.63% | 20.58% | 23.71% | 23.18% | Upgrade |
Revenue as Reported | 51,021 | 49,046 | 27,595 | 21,642 | 11,160 | 7,058 | Upgrade |
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.